Max Healthcare to introduce 24×7 ward monitoring system

New Delhi, To bring Intensive Care Unit (ICU)-standard monitoring across general wards, Max Healthcare on Wednesday announced a partnership with US-based medical technology company Vios Medical to launch a continuous vital monitoring system built on a medical-grade Internet of Things (IoT) framework.

The technology provides continuous monitoring of vital signs such as oxygen saturation, heart rate, respiratory rate, electrocardiogram (ECG) and blood pressure in general wards, thereby enabling early detection and critical care facility even outside an ICU set-up.

The VIOS ward monitoring system comprises two connected sensors — chest and finger — which communicate wirelessly (via Bluetooth) with a bed-side tablet that maps all vital trends.

These, along with alarms (in case of adverse episodes/ change in trends), can be remotely viewed by nursing staff and clinicians at nursing stations and smartphones via web links.

This ensures that hospital staff can continuously monitor even the patients who are in rooms and ensure better care, Max Healthcare said in a statement.

“The psychosis/anxiety felt by patients under long term critical care has a strong impact on their recovery. With this technology solution, patients can experience 24×7 critical monitoring, even outside an ICU environment, helping them recover in the comfortable presence of loved ones,” said Sandeep Budhiraja, Clinical Director at Max Healthcare.

The technology also aids clinicians in making more effective treatment plans by providing vital trends and patterns, the statement added.

A successful pilot of the system, covering several specialties such as Cardiology, Pulmonology, Medicine and Neurology was conducted at Max Healthcare, Dehradun.

The system, which has the potential to reduce up to 30 per cent critical care costs as compared to ICU charges, will be launched soon across all network hospitals under Max Healthcare, the statement added.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’